Avaliação bioquímica e hostológica de fígado de ratas wistar diabéticas e tratadas com tamoxifeno

Detalhes bibliográficos
Autor(a) principal: Jatobá, Carlos André Nunes
Data de Publicação: 2007
Tipo de documento: Tese
Idioma: por
Título da fonte: Repositório Institucional da UFRN
Texto Completo: https://repositorio.ufrn.br/jspui/handle/123456789/13111
Resumo: Tamoxifen (TX), a drug used in the treatment of breast cancer, may cause hepatic changes in some patients. The consequences of its use on the liver tissues of rats with or without diabetes mellitus (DM) have not been fully explored. The purpose of this multidisciplinary study was to evaluate the correlation between plasma hepatic enzyme levels and the presence of iron overload in the hepatic tissue of female Wistar rats with or without streptozotocin-induced DM and using TX. Female rats were studied in control groups: C-0 (non-drug users), C-V (sorbitol vehicle only) and C-TX (using TX). DM (diabetic non-drug users) and DM-TX (diabetics using TX) were the test groups. Sixty days after induced DM, blood samples were collected for glucose, alanine aminotransferase (ALT), aspartate aminotransferase (AST) alkaline phosphatase (ALP) and bilirubin measures. Hepatic fragments were processed and stained with hematoxylin and eosin (H&E), Masson s trichrome, Perls. The hepatic iron content was quantified by atomic absorption spectrometry. AST, ALT and ALP levels were significantly elevated in the DM and DM-TX groups, with unchanged bilirubin levels. Liver iron overload using Perls stain and atomic absorption spectrometry were observed exclusively in groups C-TX and DM-TX. There was positive correlation between AST, ALT and ALP levels and microscopic hepatic siderosis intensity in group DM-TX. In conclusion, TX administration is associated with liver siderosis in diabetic and non-diabetic rats. In addition, TX induced liver iron overload with unaltered hepatic function in 2 non-diabetic rats and may be a useful tool for investigating the biological control of iron metabolism
id UFRN_b468397f242bc9352f208330c4b9ca25
oai_identifier_str oai:https://repositorio.ufrn.br:123456789/13111
network_acronym_str UFRN
network_name_str Repositório Institucional da UFRN
repository_id_str
spelling Jatobá, Carlos André Nuneshttp://lattes.cnpq.br/8755924262557104http://lattes.cnpq.br/2365612055067945Jucá, Norma Thoméhttp://lattes.cnpq.br/8130614546005007Marchini, Júlio Sérgiohttp://lattes.cnpq.br/2038597037372097Araújo, Ana Cristina Pinheiro Fernandes dehttp://lattes.cnpq.br/7207146627442417Melo, áurea Nogueira dehttp://lattes.cnpq.br/70501756691664362014-12-17T14:13:20Z2008-03-052014-12-17T14:13:20Z2007-10-19JATOBÁ, Carlos André Nunes. Avaliação bioquímica e hostológica de fígado de ratas wistar diabéticas e tratadas com tamoxifeno. 2007. 12 f. Tese (Doutorado em Ciências da Saúde) - Universidade Federal do Rio Grande do Norte, Natal, 2007.https://repositorio.ufrn.br/jspui/handle/123456789/13111Tamoxifen (TX), a drug used in the treatment of breast cancer, may cause hepatic changes in some patients. The consequences of its use on the liver tissues of rats with or without diabetes mellitus (DM) have not been fully explored. The purpose of this multidisciplinary study was to evaluate the correlation between plasma hepatic enzyme levels and the presence of iron overload in the hepatic tissue of female Wistar rats with or without streptozotocin-induced DM and using TX. Female rats were studied in control groups: C-0 (non-drug users), C-V (sorbitol vehicle only) and C-TX (using TX). DM (diabetic non-drug users) and DM-TX (diabetics using TX) were the test groups. Sixty days after induced DM, blood samples were collected for glucose, alanine aminotransferase (ALT), aspartate aminotransferase (AST) alkaline phosphatase (ALP) and bilirubin measures. Hepatic fragments were processed and stained with hematoxylin and eosin (H&E), Masson s trichrome, Perls. The hepatic iron content was quantified by atomic absorption spectrometry. AST, ALT and ALP levels were significantly elevated in the DM and DM-TX groups, with unchanged bilirubin levels. Liver iron overload using Perls stain and atomic absorption spectrometry were observed exclusively in groups C-TX and DM-TX. There was positive correlation between AST, ALT and ALP levels and microscopic hepatic siderosis intensity in group DM-TX. In conclusion, TX administration is associated with liver siderosis in diabetic and non-diabetic rats. In addition, TX induced liver iron overload with unaltered hepatic function in 2 non-diabetic rats and may be a useful tool for investigating the biological control of iron metabolismO tamoxifeno® (TX), utilizado no tratamento do câncer de mama, pode causar alterações hepáticas. As conseqüências de seu uso em tecido hepático de ratos com ou sem diabetes mellitus (DM) não foram completamente investigadas. O estudo de caráter multidisciplinar visou avaliar a correlação entre níveis de enzimas hepáticas no plasma e a presença de sobrecarga de ferro em tecido hepático de ratas com ou sem DM induzido por estreptozotocina e em uso de TX. Ratas Wistar foram estudadas em grupos¬ controle: C-O (sem uso de droga), C-V (somente sorbitol) e C-TX (em uso de TX). DM (diabéticos sem uso de droga) e DM-TX (diabéticos em uso de TX) foram os grupos teste. Sessenta dias após a indução do DM, amostras de sangue foram colhidas para a mensuração de glicose, alanina aminotransferase (ALT), aspartato aminotransferase (AST) , fosfatase alcalina (ALP) e bilirrubina. Amostras hepáticas foram coradas com hematoxilina e eosina, Tricrômio de Masson e Perls. O conteúdo hepático de ferro foi quantificado por espectrometria de absorção atômica. AST, ALT e ALP apresentaram-se significativamente elevados nos grupos DM e DM-TX, com bilirrubina não alterada. Siderose à coloração Perls e pela espectrometria de absorção atômica foram observados apenas nos grupos C-TX e DM-TX. Houve correlação positiva entre os níveis de AST, ALT e ALP e a intensidade da siderose hepática microscópica no grupo DM-TX. Em conclusão, o uso de TX é associada com siderose hepática em ratas diabéticas ou não. O TX induziu sobrecarga hepática de ferro sem alterar a função hepática em animais não diabéticos e pode ser uma ferramenta útil no estudo do metabolismo do ferro.A participação de pesquisadores em Patologia, Cirurgia Experimental, Farmácia Clínica, Toxicologia, Nutrição, Mastologia, Endocrinologia e Biologia Molecular do Centro de Ciências da Saúde (CCS) e o Departamento de Estatística do Centro de Ciências Exatas e da Terra (CCET), de forma integrada e coordenada, foi fundamental para a execução do projeto proposto, de caráter multidisciplinarapplication/pdfporUniversidade Federal do Rio Grande do NortePrograma de Pós-Graduação em Ciências da SaúdeUFRNBRCiências da SaúdeFígadoHemossiderinaSideroseFerroTamoxifenoLiverHemosiderinSiderosisIron overloadTamoxifenCNPQ::CIENCIAS DA SAUDEAvaliação bioquímica e hostológica de fígado de ratas wistar diabéticas e tratadas com tamoxifenoinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRNinstname:Universidade Federal do Rio Grande do Norte (UFRN)instacron:UFRNTEXTCarlosANJ.pdf.txtCarlosANJ.pdf.txtExtracted texttext/plain1912https://repositorio.ufrn.br/bitstream/123456789/13111/6/CarlosANJ.pdf.txt872e6ab306ff2f52cde1e7ff9c676c4fMD56AvaliacaoBioquímicaHostológica_Jatobá_2007.pdf.txtAvaliacaoBioquímicaHostológica_Jatobá_2007.pdf.txtExtracted texttext/plain1913https://repositorio.ufrn.br/bitstream/123456789/13111/8/AvaliacaoBioqu%c3%admicaHostol%c3%b3gica_Jatob%c3%a1_2007.pdf.txt32ca02da4657bd0da6b8fdd1bc9be358MD58THUMBNAILCarlosANJ.pdf.jpgCarlosANJ.pdf.jpgIM Thumbnailimage/jpeg2471https://repositorio.ufrn.br/bitstream/123456789/13111/7/CarlosANJ.pdf.jpg168e407ceb9df0687a91dd3d4c0949ffMD57AvaliacaoBioquímicaHostológica_Jatobá_2007.pdf.jpgAvaliacaoBioquímicaHostológica_Jatobá_2007.pdf.jpgGenerated Thumbnailimage/jpeg1261https://repositorio.ufrn.br/bitstream/123456789/13111/9/AvaliacaoBioqu%c3%admicaHostol%c3%b3gica_Jatob%c3%a1_2007.pdf.jpg65010d031dd7cd1f89ef311448aea653MD59ORIGINALAvaliacaoBioquímicaHostológica_Jatobá_2007.pdfapplication/pdf292862https://repositorio.ufrn.br/bitstream/123456789/13111/1/AvaliacaoBioqu%c3%admicaHostol%c3%b3gica_Jatob%c3%a1_2007.pdf36f729a3d08d7c1e5c99393f43d9acefMD51123456789/131112019-05-26 03:02:10.384oai:https://repositorio.ufrn.br:123456789/13111Repositório de PublicaçõesPUBhttp://repositorio.ufrn.br/oai/opendoar:2019-05-26T06:02:10Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN)false
dc.title.por.fl_str_mv Avaliação bioquímica e hostológica de fígado de ratas wistar diabéticas e tratadas com tamoxifeno
title Avaliação bioquímica e hostológica de fígado de ratas wistar diabéticas e tratadas com tamoxifeno
spellingShingle Avaliação bioquímica e hostológica de fígado de ratas wistar diabéticas e tratadas com tamoxifeno
Jatobá, Carlos André Nunes
Fígado
Hemossiderina
Siderose
Ferro
Tamoxifeno
Liver
Hemosiderin
Siderosis
Iron overload
Tamoxifen
CNPQ::CIENCIAS DA SAUDE
title_short Avaliação bioquímica e hostológica de fígado de ratas wistar diabéticas e tratadas com tamoxifeno
title_full Avaliação bioquímica e hostológica de fígado de ratas wistar diabéticas e tratadas com tamoxifeno
title_fullStr Avaliação bioquímica e hostológica de fígado de ratas wistar diabéticas e tratadas com tamoxifeno
title_full_unstemmed Avaliação bioquímica e hostológica de fígado de ratas wistar diabéticas e tratadas com tamoxifeno
title_sort Avaliação bioquímica e hostológica de fígado de ratas wistar diabéticas e tratadas com tamoxifeno
author Jatobá, Carlos André Nunes
author_facet Jatobá, Carlos André Nunes
author_role author
dc.contributor.authorID.por.fl_str_mv
dc.contributor.authorLattes.por.fl_str_mv http://lattes.cnpq.br/8755924262557104
dc.contributor.advisorID.por.fl_str_mv
dc.contributor.advisorLattes.por.fl_str_mv http://lattes.cnpq.br/2365612055067945
dc.contributor.referees1.pt_BR.fl_str_mv Jucá, Norma Thomé
dc.contributor.referees1ID.por.fl_str_mv
dc.contributor.referees1Lattes.por.fl_str_mv http://lattes.cnpq.br/8130614546005007
dc.contributor.referees2.pt_BR.fl_str_mv Marchini, Júlio Sérgio
dc.contributor.referees2ID.por.fl_str_mv
dc.contributor.referees2Lattes.por.fl_str_mv http://lattes.cnpq.br/2038597037372097
dc.contributor.referees3.pt_BR.fl_str_mv Araújo, Ana Cristina Pinheiro Fernandes de
dc.contributor.referees3ID.por.fl_str_mv
dc.contributor.referees3Lattes.por.fl_str_mv http://lattes.cnpq.br/7207146627442417
dc.contributor.referees4.pt_BR.fl_str_mv Melo, áurea Nogueira de
dc.contributor.referees4ID.por.fl_str_mv
dc.contributor.referees4Lattes.por.fl_str_mv http://lattes.cnpq.br/7050175669166436
dc.contributor.author.fl_str_mv Jatobá, Carlos André Nunes
dc.subject.por.fl_str_mv Fígado
Hemossiderina
Siderose
Ferro
Tamoxifeno
topic Fígado
Hemossiderina
Siderose
Ferro
Tamoxifeno
Liver
Hemosiderin
Siderosis
Iron overload
Tamoxifen
CNPQ::CIENCIAS DA SAUDE
dc.subject.eng.fl_str_mv Liver
Hemosiderin
Siderosis
Iron overload
Tamoxifen
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS DA SAUDE
description Tamoxifen (TX), a drug used in the treatment of breast cancer, may cause hepatic changes in some patients. The consequences of its use on the liver tissues of rats with or without diabetes mellitus (DM) have not been fully explored. The purpose of this multidisciplinary study was to evaluate the correlation between plasma hepatic enzyme levels and the presence of iron overload in the hepatic tissue of female Wistar rats with or without streptozotocin-induced DM and using TX. Female rats were studied in control groups: C-0 (non-drug users), C-V (sorbitol vehicle only) and C-TX (using TX). DM (diabetic non-drug users) and DM-TX (diabetics using TX) were the test groups. Sixty days after induced DM, blood samples were collected for glucose, alanine aminotransferase (ALT), aspartate aminotransferase (AST) alkaline phosphatase (ALP) and bilirubin measures. Hepatic fragments were processed and stained with hematoxylin and eosin (H&E), Masson s trichrome, Perls. The hepatic iron content was quantified by atomic absorption spectrometry. AST, ALT and ALP levels were significantly elevated in the DM and DM-TX groups, with unchanged bilirubin levels. Liver iron overload using Perls stain and atomic absorption spectrometry were observed exclusively in groups C-TX and DM-TX. There was positive correlation between AST, ALT and ALP levels and microscopic hepatic siderosis intensity in group DM-TX. In conclusion, TX administration is associated with liver siderosis in diabetic and non-diabetic rats. In addition, TX induced liver iron overload with unaltered hepatic function in 2 non-diabetic rats and may be a useful tool for investigating the biological control of iron metabolism
publishDate 2007
dc.date.issued.fl_str_mv 2007-10-19
dc.date.available.fl_str_mv 2008-03-05
2014-12-17T14:13:20Z
dc.date.accessioned.fl_str_mv 2014-12-17T14:13:20Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv JATOBÁ, Carlos André Nunes. Avaliação bioquímica e hostológica de fígado de ratas wistar diabéticas e tratadas com tamoxifeno. 2007. 12 f. Tese (Doutorado em Ciências da Saúde) - Universidade Federal do Rio Grande do Norte, Natal, 2007.
dc.identifier.uri.fl_str_mv https://repositorio.ufrn.br/jspui/handle/123456789/13111
identifier_str_mv JATOBÁ, Carlos André Nunes. Avaliação bioquímica e hostológica de fígado de ratas wistar diabéticas e tratadas com tamoxifeno. 2007. 12 f. Tese (Doutorado em Ciências da Saúde) - Universidade Federal do Rio Grande do Norte, Natal, 2007.
url https://repositorio.ufrn.br/jspui/handle/123456789/13111
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal do Rio Grande do Norte
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Ciências da Saúde
dc.publisher.initials.fl_str_mv UFRN
dc.publisher.country.fl_str_mv BR
dc.publisher.department.fl_str_mv Ciências da Saúde
publisher.none.fl_str_mv Universidade Federal do Rio Grande do Norte
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRN
instname:Universidade Federal do Rio Grande do Norte (UFRN)
instacron:UFRN
instname_str Universidade Federal do Rio Grande do Norte (UFRN)
instacron_str UFRN
institution UFRN
reponame_str Repositório Institucional da UFRN
collection Repositório Institucional da UFRN
bitstream.url.fl_str_mv https://repositorio.ufrn.br/bitstream/123456789/13111/6/CarlosANJ.pdf.txt
https://repositorio.ufrn.br/bitstream/123456789/13111/8/AvaliacaoBioqu%c3%admicaHostol%c3%b3gica_Jatob%c3%a1_2007.pdf.txt
https://repositorio.ufrn.br/bitstream/123456789/13111/7/CarlosANJ.pdf.jpg
https://repositorio.ufrn.br/bitstream/123456789/13111/9/AvaliacaoBioqu%c3%admicaHostol%c3%b3gica_Jatob%c3%a1_2007.pdf.jpg
https://repositorio.ufrn.br/bitstream/123456789/13111/1/AvaliacaoBioqu%c3%admicaHostol%c3%b3gica_Jatob%c3%a1_2007.pdf
bitstream.checksum.fl_str_mv 872e6ab306ff2f52cde1e7ff9c676c4f
32ca02da4657bd0da6b8fdd1bc9be358
168e407ceb9df0687a91dd3d4c0949ff
65010d031dd7cd1f89ef311448aea653
36f729a3d08d7c1e5c99393f43d9acef
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN)
repository.mail.fl_str_mv
_version_ 1797777152563740672